Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Masciotra, Silvina ^a   Smith, Amanda J ^a   Youngpairoj, Ae S ^a   Sprinkle, Patrick ^a   Miles, Isa ^a   Sionean, Catlainn ^a   Paz Bailey, Gabriela ^a   Johnson, Jeffrey A ^a   Owen, S Michele ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Algorithms; Diagnostics; HIV 1; Laboratory

Indexed keywords

ALGORITHM; ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MALE; MEN WHO HAVE SEX WITH MEN; MULTISPOT HIV 1 HIV 2 ASSAY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SCREENING TEST; UNITED STATES;

ALGORITHMS; DIAGNOSTICS; HIV-1; LABORATORY;

ALGORITHMS; DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HIV-1; HIV-2; HOMOSEXUALITY, MALE; HUMANS; IMMUNOASSAY; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; UNITED STATES; URBAN POPULATION;

EID: 84890194812     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.002     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1, infections. Morb Mortal Wkly Rep 1989;38(S7):1-7.
2. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46:1588-1595.
3. Barbe F., Kelin M., Badonnel Y. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and Western blot. Ann Biol Clin 1994, 52:341-345.
4. Constantine N.T., van der Groen G., Belsey E., Tamashiro H. Sensitivity of HIV antibody assays as determined by seroconversion panels. AIDS 1994, 8:1715-1720.
5. Louie B., Pandori M., Wong E., Klausner J.D., Liska S. Use of an acute seroconversion panel to evaluate a third-generation enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies relative to multiple other assays. J Clin Microbiol 2006, 44:1856-1858.
6. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52S:S17-S22.
7. Chavez P., Wesolowski L., Patel P., Delaney K., Owen S.M. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab combo assay. J Clin Virol 2011, 52S:S51-S55.
8. Bentsen C., McLaughlin L., Mitchell E., Ferrera C., Liska S., Myers R., et al. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (group M and O) and HIV-2 in human serum or plasma. J Clin Virol 2011, 52S:S57-S61.
9. Pilcher C.D., Joaki G., Hoffman I.F., Martinson F.E.A., Mapanje C., Stewart P.W., et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007, 21:1723-1730.
10. Cohen M.S., Gay C.L., Bush M.P., Hecht F.M. The detection of acute HIV infection. J Infect Dis 2010, 202(S2). S270-S77.
11. Eshleman S.H., Khaki L., Laeyendecker O., Piwowar-Manning E., Johnson-Lewis L., Husnik M., et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab combo assay. J Acquir Immune Defic Syndr 2009, 52:121-124.
12. Pandori M.W., Hackett J., Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microb 2009, 47:2639-2642.
13. Patel P., Mackellar D., Simmons P., Uniyal A., Gallagher K., Bennet B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170:66-74.
14. Owen S.M. Testing for acute HIV infection: implications for treatment as prevention. Curr Opin HIV AIDS 2012, 7:125-130.
15. Association of Public Health Laboratories and the Centers for Disease Control & Prevention. HIV Testing Algorithms - A Status Report. Available at:. http://www.aphl.org/aphlprograms/infectious/hiv/Documents/StatusReportFINAL.pdf.
16. Pandori M.W., Branson B.M. 2010 HIV diagnostics conference. Expert Rev Anti Infect Ther 2010, 8:631-633.
17. Pilcher C.D., Christopoulos K.A., Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 2010, 201(Suppl. 1):S7-S15.
18. O'Connell R.J., Peel S.A. Multispot™ HIV-1/HIV-2 rapid test: advantages over the other rapid HIV tests. Expert Rev Mol Diagn 2007, 7:499-505.
19. Nasrullah M., Ethridge S.F., Delaney K.P., Wesolowski L.G., Granade T.C., Schwendemann J., et al. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the multispot HIV-1/HIV-2 rapid test for classifying HIV-1 and HIV-2 infections. J Clin Virol 2011, 52S:S23-S27.
20. Nasrullah M., Wesolowski L.G., Meyer W.A., Owen M., Masciotra S., Vorwald C., et al. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS 2012, 27:731-737.
21. Wesolowski L.G., Delaney K.P., Hart C., Dawson C., Owen S.M., Candal D., et al. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol 2011, 52S:S45-S49.
22. Delaney K.P., Heffelfinger J.D., Wesolowski L.G., Owen S.M., Meyer W.A., Kennedy S., et al. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol 2011, 52S:S5-S10.
23. Gallaher K.M., Sullivan P.S., Lansky A., Onorato I.M. Behavioral surveillance among people at risk for HIV infection in the US: the National HIV Behavioral Surveillance System. Public Health Rep 2007, 122(Suppl. 1):32-38.
24. MacKellar D.A., Gallaguer K.M., Finlayson T., Sanchez T., Lansky A., Sullivan P.S. Surveillance of HIV risk and prevention behaviors of men who have sex with men - a national application of venue-based, time-space sampling. Public Health Rep 2007, 122(Suppl. 1):39-47.
25. Wejnert C, Le B, Zhu J, Finlayson T, Oster A, Smith A, et al. HIV prevalence and awareness of infection in 2008 and 2011 among MSM: 20 US cities. In: Conference on Retroviruses and Opportunistic Infections; 2013. Link available online was deleted by the conference:. http://www.retroconference.org/2013b/Abstracts/45701.htm.
26. Prevalence and awareness of HIV infection among men who have sex with men - 21 cities, United States, 2008. Morb Mortal Wkly Rep 2010;59:1201-7.
27. Neumann D, Bennett B, Gillis L. Performance of the new HIV-1/2 diagnostic algorithm in Florida's Public Health Testing Population: a review of the first five months of utilization. In: 2012 HIV Diagnostics Conference, 2012. Atlanta, GA. Available at:. http://www.cvent.com/events/2012-hiv-diagnostics-conference/custom-128-7213a1d01a6341dbbf81115a21797240.aspx.
28. Pavie J., Rachline A., Loze B., Niedbalski L., Delaugerre C., Laforgerie E., et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS ONE 2010, 5:e11581.
29. Hamers R.L., de Beer I.H., Kaura H., van Vugt M., Caparos L., Rinke de Wit T.F. Diagnostic accuracy of two oral fluid-based tests for HIV surveillance in Namibia. J Acquir Immune Defic Syndr 2008, 1:116-118.
30. Sherman G., Lilian R., Coovadia A. Oral fluid tests for screening of human immunodeficiency virus-exposed infants. Pediatr Infect Dis J 2010, 2:169-172.
31. Luo W., Masciotra S., Delaney K., Charurat M., Croxton T., Constantine N., et al. Comparison of HIV oral fluid and plasma testing during early infection in a longitudinal Nigerian cohort. J Clin Virol 2013, 58(Suppl. 1):e113-e118.
32. O'Connell R.J., Merritt T.M., Malia J.A., VanCott T.C., Dolan M.J., Zahwa H., et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003, 41:2153-2155.
33. Stekler J.D., Swenson P.D., Coombs R.W., Dragavon J., Thomas K.K., Brennan C.A., et al. HIV testing in a high-incidence population: is antibody testing alone good enough?. Clin Infect Dis 2009, 49:444-453.
34. Patel P., Klausner J.D., Bacon O.M., Liska S., Taylor M., Gonzalez A., et al. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr 2006, 42:75-79.
35. Acute HIV infection: New York City, 2008. Morb Mortal Wkly Rep 2009;58:1296-9.
36. Smith K., Powers K.A., Kashuba A.D., Cohen M.S. HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS 2011, 6:315-325.